How Much Did Elekta Raise?
Funding & Key Investors

Elekta, a cornerstone in the global oncology technology sector, has successfully secured a major strategic investment totaling $200M. This capital injection brings the firm's cumulative financial backing to $200M, reinforcing its long-standing commitment to advancing precision radiation medicine. By leveraging this significant infusion of resources, the Stockholm-based enterprise continues to solidify its influence within the competitive landscape of medical technology and clinical oncology infrastructure.

What is Elekta?

Elekta
ManufacturingMedical Devices & Equipment

Founded in 1972, Elekta has evolved into a premier provider of sophisticated radiation therapy and radiosurgery systems. The company specializes in the development of high-precision equipment and integrated clinical management software designed to address complex cancer cases and neurological disorders. With a robust portfolio that spans hardware innovation and digital health solutions, Elekta maintains a critical market position by enabling healthcare providers to deliver personalized, evidence-based treatment protocols. Its operational focus remains centered on improving patient outcomes through technological excellence and seamless clinical workflow integration.

How much funding has Elekta raised?

Elekta has raised a total of $200M across 1 funding round:

2011

Debt

$200M

Debt (2011): $200M, investors not publicly disclosed

Key Investors in Elekta

Undisclosed Institutional Partner

An undisclosed institutional investor providing strategic debt financing to support long-term corporate growth and operational stability.

Undisclosed Private Equity Firm

A private equity entity focused on large-scale capital deployment within the healthcare and medical technology sectors.

Undisclosed Strategic Lender

A strategic lender specializing in debt instruments for established multinational corporations in the life sciences industry.

What's next for Elekta?

Looking ahead, the recent capital allocation is expected to accelerate Elekta's research and development initiatives, particularly in the realms of adaptive radiotherapy and AI-driven clinical decision support. As the company navigates the complexities of the global healthcare market, this strategic financing provides the necessary liquidity to scale its digital health ecosystem and expand its footprint in emerging markets. By prioritizing innovation in non-invasive treatment modalities, Elekta is well-positioned to maintain its leadership trajectory, ensuring that its clinical management solutions remain at the forefront of the oncology sector's digital transformation.

See full Elekta company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Food & BeverageManufacturing
Building MaterialsManufacturingFreight & Logistics ServicesTransportationTrucking, Moving & Storage
Building MaterialsManufacturingConstruction ManagementConstruction
ManufacturingWire & CableElectronics

Frequently Asked Questions Regarding Elekta Financial Insights

What are the most recent funding rounds that Elekta has completed, and what were the funding rounds?
Elekta has recently completed 1 funding rounds: Debt on May 4, 2011.
What is the total amount of funding Elekta has raised to date?
Elekta has raised a total of $200M in funding to date.
How many funding rounds has Elekta completed?
Elekta has completed 1 funding rounds.
How much funding did Elekta raise in its most recent funding round?
Elekta raised $200M in its most recent funding round.
Which was the largest funding round in Elekta's history?
The largest funding round in Elekta's history was $200M.
See more information about Elekta